Theodora Angoulvant-Bejan
Tours, 37044, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Fibrosis and hypertension: association but not causation.
Journal: European journal of preventive cardiology
Published: May 07, 2026
Potassium on the Spot: interpreting cardiovascular risk in CKD.
Journal: European journal of preventive cardiology
Published: April 21, 2026
Renal Histology Findings in Malignant Hypertension, a Systematic Review.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: November 04, 2025
Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics.
Journal: Clinical pharmacokinetics
Published: July 06, 2025
Targets for treatment and optimal strategies for managing hypertension in 2025: indications for clinical practice from recent hypertension guidelines.
Journal: European journal of preventive cardiology
Published: June 23, 2025
SGLT2 inhibitors: towards a personalized prescription.
Journal: European journal of preventive cardiology
Published: April 15, 2025
Clinical usefulness of anti-α3Gal immunoglobulin E assays for cetuximab-mediated anaphylaxis in head and neck cancer.
Journal: Immuno-oncology technology
Published: March 19, 2025
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial).
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: February 09, 2025
Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol.
Journal: BMJ open
Published: September 11, 2024
Contemporary Epidemiology, Management, and In-Hospital Outcomes of Acute Myocarditis: The Prospective Multicenter MyocarditIRM Study.
Journal: JACC. Heart failure
Published: September 06, 2024
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial.
Journal: Respiratory medicine and research
Published: August 13, 2024
Hypertension and Cardiovascular Outcomes in Inflammatory and Autoimmune Diseases: A Systematic Review and Meta-analysis.
Journal: Current hypertension reports
Published: May 14, 2024
Last Updated: 09/26/2026